Glecaprevir

ATC J05AP57 · 10 markets · 22 records

Glecaprevir 10 markets · 22 records Forms

Filters

MarketAU 5 GB 4 US 2 CA 2 ES 2 FR 2 SG 1 TW 1 HK 1 EU 1

Kind

Strength

AU 5 records · 2 shown of 2 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Combination products containing this ingredient

100 mgtablet CombinationGlecaprevir 100 mg + Pibrentasvir 40 mgMaviret 100mg/40mg tablets+2MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet blister pack、MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet bottle also in GB·US·CA
+2Other 2 markets
FR SG
unknown
50 mgpowder CombinationGlecaprevir 50 mg + Pibrentasvir 20 mgMAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet also in GB·CA·FR unknown

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Maviret 100mg/40mg tablets ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

GB 4 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

Combination products containing this ingredient

100 mgtablet CombinationGlecaprevir 100 mg + Pibrentasvir 40 mgMaviret 100mg/40mg tablets+1Manufacturer: AbbVie Ltd also in AU·US·CA
+2Other 2 markets
FR SG
50 mgpowder CombinationGlecaprevir 50 mg + Pibrentasvir 20 mgMaviret 50mg/20mg granules sachets+1Manufacturer: AbbVie Ltd also in AU·CA·FR

US 2 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

Combination products containing this ingredient

100 mgtablet CombinationGlecaprevir 100 mg + Pibrentasvir 40 mgMavyret also in AU·GB·CA
+2Other 2 markets
FR SG
50 mgpellet CombinationGlecaprevir 50 mg + Pibrentasvir 20 mgMavyret

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Combination products containing this ingredient

100 mgtablet CombinationGlecaprevir 100 mg + Pibrentasvir 40 mgMaviret 100mg/40mg tablets also in AU·GB·US
+2Other 2 markets
FR SG
50 mgpowder CombinationGlecaprevir 50 mg + Pibrentasvir 20 mgMaviret 100mg/40mg tablets also in AU·GB·FR

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

Combination products containing this ingredient

40 mgtablet CombinationGlecaprevir 40 mg + PibrentasvirMaviret 100mg/40mg tablets
50 mgliquid CombinationGlecaprevir 50 mg + Pibrentasvir 20 mgMAVIRET GRANULOS

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

Combination products containing this ingredient

100 mgtablet CombinationGlecaprevir 100 mg + Pibrentasvir 40 mgMAVIRET 100 mg/40 mg, comprimé pelliculé also in AU·GB·US
+2Other 2 markets
CA SG
50 mgpowder CombinationGlecaprevir 50 mg + Pibrentasvir 20 mgMAVIRET 50 mg/20 mg, granulés enrobés en sachet also in AU·GB·CA

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Combination products containing this ingredient

100 mgtablet CombinationGlecaprevir 100 mg + Pibrentasvir 40 mgMaviret 100mg/40mg tablets also in AU·GB·US
+2Other 2 markets
CA FR

TW 1 records · 0 shown of 0 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Maviret 100mg/40mg tablets ×6艾百樂膜衣錠100毫克/40毫克 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Maviret 100mg/40mg tablets ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Maviret 100mg/40mg tablets ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	TW	HK	EU	FR
100 mg Combination Glecaprevir 100 mg + Pibrentasvir 40 mg tablet	Mavyret	Manufacturer: AbbVie Ltd ×2 Maviret 100mg/40mg tablets	Maviret 100mg/40mg tablets	Maviret 100mg/40mg tablets MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet blister pack MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet bottle	Maviret 100mg/40mg tablets	not recorded	not recorded	not recorded	not recorded	MAVIRET 100 mg/40 mg, comprimé pelliculé
50 mg Combination Glecaprevir 50 mg + Pibrentasvir 20 mg powder	not recorded	Manufacturer: AbbVie Ltd ×2 Maviret 50mg/20mg granules sachets	Maviret 100mg/40mg tablets	MAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet	not recorded	not recorded	not recorded	not recorded	not recorded	MAVIRET 50 mg/20 mg, granulés enrobés en sachet
40 mg Combination Glecaprevir 40 mg + Pibrentasvir tablet	not recorded	not recorded	not recorded	not recorded	not recorded	Maviret 100mg/40mg tablets	not recorded	not recorded	not recorded	not recorded
50 mg Combination Glecaprevir 50 mg + Pibrentasvir 20 mg liquid	not recorded	not recorded	not recorded	not recorded	not recorded	MAVIRET GRANULOS	not recorded	not recorded	not recorded	not recorded
50 mg Combination Glecaprevir 50 mg + Pibrentasvir 20 mg pellet	Mavyret	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed Combination Glecaprevir + Pibrentasvir unknown	not recorded	not recorded	not recorded	Maviret 100mg/40mg tablets	not recorded	not recorded	not recorded	Maviret 100mg/40mg tablets	Maviret 100mg/40mg tablets	not recorded
not disclosed Combination Glecaprevir + Pibrentasvir tablet	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Maviret 100mg/40mg tablets 艾百樂膜衣錠100毫克/40毫克	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

3 more strength/form rows are recorded only in ES · TW and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en ES · TW que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 ES · TW 有记录（未在本表显示）。另有 3 個規格/劑型僅在 ES · TW 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.